<DOC>
	<DOCNO>NCT00476489</DOCNO>
	<brief_summary>The purpose study determine topical steroid treatment different skin disease suppress adrenal cortisol production .</brief_summary>
	<brief_title>Does Topical Steroid Treatment Impair Adrenal Function ?</brief_title>
	<detailed_description>Adrenocortical suppression potential complication systemic corticosteroid treatement also non systemic therapy like topical therapy . The normalcy hypothalamic-pituitary-adrenal axis ( HPA axis ) patient chronic skin disease like atopic dermatitis , pemphigus psoriasis treat topical steroid , assess low dose ( 1mcg ) adrenocortocotropin ( ACTH ) stimulation test . During test serum cortisol level measure , 30 60 mn intravenous administration 1mcg ACTH ( synacthen ) .The result compare age sex match subject normal HPA axis assess low dose ACTH stimulation test .</detailed_description>
	<mesh_term>Pituitary Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>patient receive daily topical steroid least two week 10 % body surface . patient treat form corticosteroid except topical steroid . patient know pituitary disease pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>secondary adrenal insuffiency</keyword>
	<keyword>hypothalamus-pituitary-adrenal axis impairement</keyword>
	<keyword>topical steroid</keyword>
</DOC>